Showing results (1-10 of 395) with videos related to
Sort By:
Pageof 40
European Journal of Gastroenterology & Hepatology|May 8, 2001
Pathogenesis of portal hypertensionD Lebrec, R MoreauBest Practice & Research. Clinical Gastroenterology|May 18, 2001
Regulation of splanchnic perfusionR Moreau, D LebrecGastroenterologie Clinique Et Biologique|June 23, 2009
[Progress in portal hypertension]D Lebrec, R MoreauAlimentary Pharmacology & Therapeutics|September 1, 2004
Review article: hepatorenal syndrome--definitions and diagnosisR Moreau, D LebrecLiver|February 1, 1994
Effects of vasopressin on haemodynamics in portal hypertensive rats receiving clonidineR Moreau, S Cailmail, D LebrecActa Gastro-Enterologica Belgica|April 10, 2008
Incidence and characteristics of type 2 hepatorenal syndrome in patients with cirrhosis and refractory ascitesT Sersté, D Lebrec, D Valla, et al.Alimentary Pharmacology & Therapeutics|November 14, 1997
Haemodynamic responses to a combination of terlipressin and octreotide in portal hypertensive ratsR Moreau, S Cailmail, D Valla, et al.Journal of Hepatology|February 1, 1997
Vascular hyporesponsiveness to vasodilators in rats with cirrhosisV Safka, R Moreau, A Gadano, et al.Journal of Hepatology|February 1, 1995
Lack of vascular hyporesponsiveness to the L-type calcium channel activator, Bay K 8644, in rats with cirrhosisM Hartleb, R Moreau, C Gaudin, et al.Journal of Hepatology|September 1, 1992
Blockade of ATP-sensitive K+ channels by glibenclamide reduces portal pressure and hyperkinetic circulation in portal hypertensive ratsR Moreau, H Komeichi, S Cailmail, et al.Pageof 40